Overview

Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder

Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of prazosin in treating post-traumatic stress disorder caused by noncombat trauma in individuals taking selective serotonin reuptake inhibitors.
Phase:
N/A
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Prazosin